JetBlue’s ‘Flight Disruptions’ Refund Policy
Clear policy or moving target?
Ozempic, Wegovy, and Other GLP-1 RA Medications
Multiple class-action lawsuits regarding the marketing of GLP-1 RAs were transferred to be heard together as part of multidistrict litigation (MDL). More information on the MDL is below.
Case Name (Date)
In Re: Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation
24-md-3094, E.D. Penn.
(2024)
Product/Service
Ozempic, Wegovy, Rybelsus, Saxenda, Victoza, Mounjaro, Zepbound, Trulicity and other GLP-1 RA medications
Allegations
Marketing products as weight-loss medications without adequately disclosing that many people stop using them due to their side effects, the medications do not result in meaningful weight loss for up to 15 percent of people, the average weight loss is approximately 10 percent of a person’s body weight, and people need to stay on them to maintain their weight loss
Status
Pending
The Latest
Almond Breeze: The Pitch.
Keeping it real isn’t always easy in a pitch meeting. Luckily, Almond Breeze is.
LifeLock’s Identity Theft Protection
Is your Social Security number as vulnerable as this company claims?
The McRib
Lawsuit alleges the McRib is a McScam.
2026 Deceptive Ad Trends
A closer look at what we’ll be monitoring in the new year.